NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
News

NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

  • By IPP Bureau | September 26, 2022

Natco Pharma Limited has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in the Indian Market.

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

Upcoming E-conference

Other Related stories

Startup

Digitization